(2R,4R)-Teneligliptin is a stereoisomer of Teneligliptin (T018300, HBr); a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion and has a half-life of 24.2 hours in the human body.
参考文献
Goda, M. & Kadowaki, T.: Drugs Today, 49, 615 (2013); Kishimoto, M.: Diabetes Metab. Syndr. Obes., 6, 187 (2012); Yoshida, T., et al.: Bioorg, Med. Chem., 20, 5705 (2012)
沪ICP备17019645号
400-821-0725
